MeSCue-Janusys Inc. announced that it expects to receive ¥50 million in funding from Cosmo Bio Company,Limited and other investors
April 09, 2019
Share
MeSCue-Janusys Inc. announced a private placement of 12,500 common shares at an issue price of ¥4,000 per share for gross proceeds of ¥50,000,000 on April 10, 2019. The transaction will involve participation from Cosmo Bio Company,Limited (JASDAQ:3386) for 6,250 shares and other investors. The company will issue shares through third-party allotment method. Post the closing, the total number of shares issued by the company will increase from 77,265 shares to 89,765 shares. The payment date is April 17, 2019. The company will sign agreement for subscription with the investors between April 10, 2019 and April 17, 2019. The transaction has been approved by the shareholders of the company.
COSMO BIO COMPANY,LIMITED is a Japan-based company mainly engaged in purchase and wholesale of research reagents, equipment, consignment services and clinical test drugs related to life science. Research reagents business imports majority research reagents from United States and Europe, which are prioritized in life science related research. In the equipment business, the Company handles equipment specialized in life science research, purchases goods from a wide range of domestic and overseas, and mainly sells it to the domestic market. The equipment includes ultrasonic cell disruption equipment, bioimaging related equipment and research consumables. The Company provides clinical test drugs mainly used at hospitals and testing centers.